personalized small-molecule inhibitors

April 2, 2024

AI is a viable alternative to high throughput screening: a 318-target study

The Atomwise AIMS Program
March 2, 2022

AtomNet PoseRanker: Enriching Ligand Pose Quality for Dynamic Proteins in Virtual High-Throughput Screens

Kate A. Stafford, Brandon M. Anderson, Jon Sorenson, and Henry van den Bedem*
June 1, 2021

SPOP and OTUD7A Control EWS–FLI1 Protein Stability to Govern Ewing Sarcoma Growth

Siyuan Su, Jianfeng Chen, Yao Jiang, Ying Wang, Tamara Vital, Jiaming Zhang, Christian Laggner, Kong T. Nguyen, Zhichuan Zhu, Alex W. Prevatte, Natalie K. Barker, Laura E. Herring, Ian J. Davis, Pengda Liu
August 18, 2020

Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development

Arash Keshavarzi Arshadi, Julia Webb, Milad Salem, Emmanuel Cruz, Stacie Callad-Thomson, Niloofar Ghadirian, Jennifer Collins, Elen Diez-Cecilia, Brendan Kelly, Hani Goodarzi, and Jiann Shiun Yuan
August 17, 2020

Current methods and challenges for deep learning in drug discovery

Stefan Schroedl